Accelerating ALS (Amyotrophic Lateral Sclerosis) therapy development. One man can and will find a way, why not be that man... Treeway B.V., is a biotech company, focus on the rational target validation and drug development therapies for the treatment and cure of Amyotrophic lateral sclerosis (ALS).
Treeway has been founded by entrepreneurs Bernard Muller and Robbert Jan Stuit, both diagnosed with ALS. Treeways strategy is founded on a cohesive combination of approaches that together should provide the highest likelihood of bringing successful treatments for ALS to the patient in the short term. Founders have also initiated Project MinE that aims to discover the genes that are associated with ALS to find the gentic causes.